Latest resources and news surrounding Novartis data featured at the 62nd American Society of Hematology Annual Meeting (ASH).
Annual meeting highlights progress on the company’s transformation and growth strategy.
Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.
Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
Novartis announced the company’s financial results for the third quarter of 2020.
Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.
Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.
September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.
Latest oncology resources and news surrounding Novartis data featured at European Society for Medical Oncology (ESMO)
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.